Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells
1998
Aromatase Inhibitors and Their Effects on Tumor Cells
publication
Evidence: moderate
Author Information
Author(s): N Harada, O Hatano
Primary Institution: Fujita Health University
Hypothesis
Aromatase inhibitors stabilize aromatase protein levels in cultured human tumor cells.
Conclusion
Aromatase inhibitors prevent the degradation of aromatase protein in tumor cells, leading to increased protein levels.
Supporting Evidence
- Aromatase inhibitors caused a fourfold increase in aromatase protein levels in JEG-3 cells after 24 hours.
- The inhibitors blocked the rapid degradation of aromatase protein induced by forskolin.
- Aromatase mRNA levels remained unchanged despite the increase in protein levels.
Takeaway
Aromatase inhibitors help keep a protein called aromatase from breaking down in certain cancer cells, which might help treat cancer.
Methodology
The study used cultured JEG-3 and HepG2 cells to assess the effects of various aromatase inhibitors on aromatase protein and mRNA levels.
Limitations
The study used high concentrations of inhibitors that may not reflect clinical doses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website